<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Feng D</submitter><funding>National Natural Science Foundation of China</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Given the age relevance of prostate cancer (PCa) and the role of mitochondrial dysfunction (MIDS) in aging, we orchestrated molecular subtypes and identified key genes for PCa from the perspective of MIDS.&lt;h4>Methods&lt;/h4>Cluster analysis, COX regression analysis, function analysis, and tumor immune environment were conducted. We performed all analyses using software R 3.6.3 and its suitable packages.&lt;h4>Results&lt;/h4>CXCL14, SFRP4, and CD38 were eventually identified to classify the PCa patients in The Cancer Genome Atlas (TCGA) database and the Gene Expression Omnibus (GEO) dataset into two distinct clusters. Patients in the cluster 2 had shorter BCR-free survival than those in the cluster 1 in terms of both TCGA database and GEO dataset. We divided the patients from the </pubmed_abstract><journal>Frontiers in oncology</journal><pagination>858479</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9019359</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy.</pubmed_title><pmcid>PMC9019359</pmcid><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Wei Q</pubmed_authors><pubmed_authors>Xiong Q</pubmed_authors><pubmed_authors>Feng D</pubmed_authors><pubmed_authors>Shi X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy.</name><description>&lt;h4>Background&lt;/h4>Given the age relevance of prostate cancer (PCa) and the role of mitochondrial dysfunction (MIDS) in aging, we orchestrated molecular subtypes and identified key genes for PCa from the perspective of MIDS.&lt;h4>Methods&lt;/h4>Cluster analysis, COX regression analysis, function analysis, and tumor immune environment were conducted. We performed all analyses using software R 3.6.3 and its suitable packages.&lt;h4>Results&lt;/h4>CXCL14, SFRP4, and CD38 were eventually identified to classify the PCa patients in The Cancer Genome Atlas (TCGA) database and the Gene Expression Omnibus (GEO) dataset into two distinct clusters. Patients in the cluster 2 had shorter BCR-free survival than those in the cluster 1 in terms of both TCGA database and GEO dataset. We divided the patients from the </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-06-18T05:02:29.836Z</modification><creation>2025-04-04T22:14:42.819Z</creation></dates><accession>S-EPMC9019359</accession><cross_references><pubmed>35463369</pubmed><doi>10.3389/fonc.2022.858479</doi></cross_references></HashMap>